Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $26.14 +4.31%
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
INM, TRI, CRVL, More
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss) (in Dollars per share): -5.69
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.43), $0.02 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $37.9 million versus the consensus estimate of $36.7 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Apple’s ’unprecedented’ memory warning adds fuel to wobbly Micron, SK hynix trade
- Sotera Health Co. (SHC) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
